RX693 RX693 (Clindamycin 300 mg)
Pill imprint RX693 RX693 has been identified as Clindamycin hydrochloride 300 mg.
Clindamycin is used in the treatment of bacterial infection; bacterial vaginitis; sinusitis; aspiration pneumonia; prevention of perinatal group b streptococcal disease (and more), and belongs to the drug class lincomycin derivatives. There is no proven risk in humans during pregnancy. Clindamycin 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RX693 RX693
- 300 mg
- 22.00 mm
- Prescription only
- Drug Class:
- Lincomycin derivatives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
FD&C Blue No. 1
ferric oxide black
|NDC Code||Manufacturer / Repackager|
|68084-0244||Amerisource Health Services|
|21695-0034||Rebel Distributors Corp (repackager)|
|68071-0398||Nucare Pharmaceuticals Inc (repackager)|
|68387-0117||Keltman Pharmaceuticals Inc (repackager)|
|23490-5333||Palmetto State Pharmaceuticals Inc (repackager)|
|33358-0089||CorePharma, LLC (repackager)|
|18837-0204||Innoviant Pharmacy Inc (repackager)|
|58016-0634||Southwood Pharmaceuticals Inc (repackager)|
|57866-3148||Direct Dispensing Inc (repackager)|
|66336-0906||Dispensing Solutions Inc. (repackager)|
|49999-0290||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about clindamycin
- Clindamycin solution
- Clindamycin suspension
- Clindamycin oral/injection
- Clindamycin (Advanced Reading)
- Clindamycin Oral, Injection, Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.